Biopharma Quarterly Deal-Making Statistics, Q1 2017
A look at financing, M&A and alliance activity January–March 2017
Biopharma financing decreased by 29% in the first quarter of 2017; conversely, M&As set a record, reaching $61.9 billion. The largest alliance of the quarter involved the microbiome.
Register for our free email digests: